Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Agnieszka Wojciechowska-Kulik, Edyta Blus, Zbigniew Kowalczyk, Zbigniew Baj & Ewa Majewska. (2020) The Effect of Noninvasive Bariatric Surgery on the Levels of Certain Adipokines and Atherosclerosis Risk Factors in Patients with Metabolic Syndrome. Journal of the American College of Nutrition 39:6, pages 481-487.
Read now
Read now
Kalaivani A.V. V. Sathibabu Uddandrao, Brahmanaidu Parim, Saravanan Ganapathy, Nivedha P. R.Sushma Chandulee Kancharla, Rameshreddy P.Swapna K.Vadivukkarasi Sasikumar. (2019) Reversal of high fat diet-induced obesity through modulating lipid metabolic enzymes and inflammatory markers expressions in rats. Archives of Physiology and Biochemistry 125:3, pages 228-234.
Read now
Read now
A. Kalaivani, V. V. Sathibabu Uddandrao, P. Brahmanaidu, Ganapathy Saravanan, P. R. Nivedha, P. Tamilmani, K. Swapna & Sasikumar Vadivukkarasi. (2018) Anti obese potential of Cucurbita maxima seeds oil: effect on lipid profile and histoarchitecture in high fat diet induced obese rats. Natural Product Research 32:24, pages 2950-2953.
Read now
Read now
Jean M Whaley, Mark Tirmenstein, Timothy P Reilly, Simon M Poucher, JoAnne Saye, Shamik Parikh & James F List. (2012) Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity 5, pages 135-148.
Read now
Read now
Harold E Bays. (2011) Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development. Expert Review of Cardiovascular Therapy 9:3, pages 265-277.
Read now
Read now
Harold Bays. (2010) Phentermine, topiramate and their combination for the treatment of adiposopathy (‘sick fat’) and metabolic disease. Expert Review of Cardiovascular Therapy 8:12, pages 1777-1801.
Read now
Read now
Harold E Bays. (2009) Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for ‘sick fat’ and metabolic disease. Expert Review of Cardiovascular Therapy 7:11, pages 1429-1445.
Read now
Read now
Marcio C Mancini & Alfredo Halpern. (2008) Orlistat in the prevention of diabetes in the obese patient. Vascular Health and Risk Management 4:2, pages 325-336.
Read now
Read now
Harold E Bays, Ann P Tighe, Richard Sadovsky & Michael H Davidson. (2008) Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Review of Cardiovascular Therapy 6:3, pages 391-409.
Read now
Read now
Harold E Bays, J Michael González-Campoy, George A Bray, Abbas E Kitabchi, Donald A Bergman, Alan Bruce Schorr, Helena W Rodbard & Robert R Henry. (2008) Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Review of Cardiovascular Therapy 6:3, pages 343-368.
Read now
Read now
André J Scheen. (2008) The future of obesity: new drugs versus lifestyle interventions. Expert Opinion on Investigational Drugs 17:3, pages 263-267.
Read now
Read now
Jozef Ukropec, Barbara Ukropcova, Timea Kurdiova, Daniela Gasperikova & Iwar Klimes. (2008) Adipose tissue and skeletal muscle plasticity modulates metabolic health. Archives of Physiology and Biochemistry 114:5, pages 357-368.
Read now
Read now
Harold Bays & Peter H Jones. (2007) Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors. Vascular Health and Risk Management 3:5, pages 733-742.
Read now
Read now
Articles from other publishers (68)
Harold Edward Bays, Shagun Bindlish & Tiffany Lowe Clayton. (2023) Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Obesity Pillars 5, pages 100056.
Crossref
Crossref
Harold E. Bays, Angela Fitch, Sandra Christensen, Karli Burridge & Justin Tondt. (2022) Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2, pages 100018.
Crossref
Crossref
Seo‐Hyeon Hwang, Dong‐Woo Kang, Mi‐Kyung Lee, Ji Yong Byeon, Hanui Park, Dong‐Hyuk Park, Kyung‐Chul Kim, Seung‐Tae Lee, Sang Hui Chu, Nam Kyu Kim & Justin Y. Jeon. (2020) Changes in DNA methylation after 6‐week exercise training in colorectal cancer survivors: A preliminary study. Asia-Pacific Journal of Clinical Oncology 18:1, pages 52-60.
Crossref
Crossref
Mihai Octavian Negrea, Bogdan Neamtu, Ioana Dobrotă, Ciprian Radu Sofariu, Roxana Mihaela Crisan, Bacila Ionut Ciprian, Carmen Daniela Domnariu & Minodora Teodoru. (2021) Causative Mechanisms of Childhood and Adolescent Obesity Leading to Adult Cardiometabolic Disease: A Literature Review. Applied Sciences 11:23, pages 11565.
Crossref
Crossref
ALEXANDRA MARZIOU, BENJAMIN AUBERT, CHARLÈNE COUTURIER, JULIEN ASTIER, CLOTHILDE PHILOUZE, PHILIPPE OBERT, JEAN-FRANÇOIS LANDRIER & CATHERINE RIVA. (2021) Combined Beneficial Effect of Voluntary Physical Exercise and Vitamin D Supplementation in Diet-induced Obese C57BL/6J Mice. Medicine & Science in Sports & Exercise 53:9, pages 1883-1894.
Crossref
Crossref
Liqun Che, Bo Ren, Yuanyuan Jia, Yujia Dong, Yanbing Wang, Jie Shan & Yuchun Wang. (2021) Feprazone Displays Antiadipogenesis and Antiobesity Capacities in in Vitro 3 T3-L1 Cells and in Vivo Mice. ACS Omega 6:10, pages 6674-6680.
Crossref
Crossref
Laura Di Renzo, Paola Gualtieri, Francesca Pivari, Laura Soldati, Alda Attinà, Claudia Leggeri, Giulia Cinelli, Maria Grazia Tarsitano, Giovanna Caparello, Elena Carrano, Giuseppe Merra, Alberto Maria Pujia, Roberta Danieli & Antonino De Lorenzo. (2020) COVID-19: Is there a role for immunonutrition in obese patient?. Journal of Translational Medicine 18:1.
Crossref
Crossref
Steven K. Malin, Sankar D. Navaneethan, Ciaran E. Fealy, Amanda Scelsi, Hazel Huang, Michael Rocco & John P. Kirwan. (2020) Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease. Obesity Science & Practice 6:3, pages 307-312.
Crossref
Crossref
María Luisa Ávila‐Escalante, Fibi Coop‐Gamas, Margarita Cervantes‐Rodríguez, Daniel Méndez‐Iturbide & Irma Isela Aranda‐González. (2020) The effect of diet on oxidative stress and metabolic diseases—Clinically controlled trials. Journal of Food Biochemistry 44:5.
Crossref
Crossref
Katarzyna Kowalska, Anna Olejnik, Joanna Zielińska-Wasielica & Mariola Olkowicz. (2019) Raspberry (Rubus idaeus L.) fruit extract decreases oxidation markers, improves lipid metabolism and reduces adipose tissue inflammation in hypertrophied 3T3-L1 adipocytes. Journal of Functional Foods 62, pages 103568.
Crossref
Crossref
Nicole M. GilbertsonNatalie Z.M. EichnerEmily M. HeistonJulian M. GaitánMonique E. FrancoisJ. Hunter MehaffeyTaryn E. HassingerPeter T. HallowellArthur WeltmanSteven K. Malin. (2019) A low-calorie diet with or without interval exercise training improves adiposopathy in obese women. Applied Physiology, Nutrition, and Metabolism 44:10, pages 1057-1064.
Crossref
Crossref
Janesca Mansur Guedes, Bruno Luiz da Silva Pieri, Thaís Fernandes Luciano, Schérolin de Oliveira Marques, Luiz Guilherme Antonacci Guglielmo & Claudio Teodoro de Souza. (2019) Muscular resistance, hypertrophy and strength training equally reduce adiposity, inflammation and insulin resistance in mice with diet-induced obesity. Einstein (São Paulo) 18.
Crossref
Crossref
Eri Hiraki, Shoko Furuta, Rika Kuwahara, Naomichi Takemoto, Toshiro Nagata, Taiki Akasaka, Bungo Shirouchi, Masao Sato, Koichiro Ohnuki & Kuniyoshi Shimizu. (2017) Anti-obesity activity of Yamabushitake (Hericium erinaceus) powder in ovariectomized mice, and its potentially active compounds. Journal of Natural Medicines 71:3, pages 482-491.
Crossref
Crossref
Jessica Murphy, Grégory Moullec & Sylvia Santosa. (2017) Factors associated with adipocyte size reduction after weight loss interventions for overweight and obesity: a systematic review and meta-regression. Metabolism 67, pages 31-40.
Crossref
Crossref
Nicola Di Daniele, Annalisa Noce, Maria Francesca Vidiri, Eleonora Moriconi, Giulia Marrone, Margherita Annicchiarico-Petruzzelli, Gabriele D’Urso, Manfredi Tesauro, Valentina Rovella & Antonino De Lorenzo. (2016) Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget 8:5, pages 8947-8979.
Crossref
Crossref
Dong-Gyu Kim, Min Jung Kang, Hwa Jin Suh, Oh Oun Kwon & Jung Hye Shin. (2016) Effect of Acacia catechu Extract on 3T3-L1 Preadipocyte Differentiation. Journal of the Korean Society of Food Science and Nutrition 45:8, pages 1107-1113.
Crossref
Crossref
Rui Liu, Na Li, Yi Lin, Mei Wang, Yongde Peng, Keidren Lewi & Qinghua Wang. (2016) Glucagon Like Peptide-1 Promotes Adipocyte Differentiation via the Wnt4 Mediated Sequestering of Beta-Catenin. PLOS ONE 11:8, pages e0160212.
Crossref
Crossref
Steven K. Malin & Sangeeta R. Kashyap. (2016) Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes. Surgery for Obesity and Related Diseases 12:6, pages 1213-1219.
Crossref
Crossref
Jane J. Lee, Alison Pedley, Udo Hoffmann, Joseph M. Massaro, John F. KeaneyJr.Jr., Ramachandran S. Vasan & Caroline S. Fox. (2016) Cross‐Sectional Associations of Computed Tomography (CT)‐Derived Adipose Tissue Density and Adipokines: The Framingham Heart Study. Journal of the American Heart Association 5:3.
Crossref
Crossref
Harold E. Bays, Peter H. Jones, Terry A. Jacobson, David E. Cohen, Carl E. Orringer, Shanu Kothari, Dan E. Azagury, John Morton, Ninh T. Nguyen, Eric C. Westman, Deborah B. Horn, Wendy Scinta & Craig Primack. (2016) Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: EXECUTIVE SUMMARY. Journal of Clinical Lipidology 10:1, pages 15-32.
Crossref
Crossref
Harold E. Bays, Peter H. Jones, Terry A. Jacobson, David E. Cohen, Carl E. Orringer, Shanu Kothari, Dan E. Azagury, John Morton, Ninh T. Nguyen, Eric C. Westman, Deborah B. Horn, Wendy Scinta & Craig Primack. (2016) Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: FULL REPORT. Journal of Clinical Lipidology 10:1, pages 33-57.
Crossref
Crossref
Ozioma Ezekwesili Ofili Josephine & Christine Gwacham Ngozi. (2015) Comparative effects of peel extract from Nigerian grown citrus on body weight, liver weight and serum lipids in rats fed a high-fat diet. African Journal of Biochemistry Research 9:9, pages 110-116.
Crossref
Crossref
Sundram Karupiah & Zhari Ismail. (2014) Anti-Obesity Effects of Melastoma malabathricum var Alba Linn in Rats Fed with a High-Fat Diet. AAPS PharmSciTech 16:3, pages 548-553.
Crossref
Crossref
Colleen Keller, Barbara Ainsworth, Kathryn Records, Michael Todd, Michael Belyea, Sonia Vega-López, Paska Permana, Dean Coonrod & Allison Nagle-Williams. (2014) A comparison of a social support physical activity intervention in weight management among post-partum Latinas. BMC Public Health 14:1.
Crossref
Crossref
S. K. Malin, J. Bena, B. Abood, C. E. Pothier, D. L. Bhatt, S. Nissen, S. A. Brethauer, P. R. Schauer, J. P. Kirwan & S. R. Kashyap. (2014) Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery. Diabetes, Obesity and Metabolism 16:12, pages 1230-1238.
Crossref
Crossref
Ved Prakash Meena, V. Seenu, M. C. Sharma, Saumya Ranjan Mallick, Ashu Seith Bhalla, Nandita Gupta, Anant Mohan, Randeep Guleria, Ravindra M. Pandey, Kalpana Luthra & Naval K. Vikram. (2014) Relationship of Adipocyte Size with Adiposity and Metabolic Risk Factors in Asian Indians. PLoS ONE 9:9, pages e108421.
Crossref
Crossref
Jichun Yang, Jihong Kang & Youfei Guan. (2013) The mechanisms linking adiposopathy to type 2 diabetes. Frontiers of Medicine 7:4, pages 433-444.
Crossref
Crossref
Samantha HockingDorit Samocha-BonetKerry-Lee MilnerJerry R. Greenfield & Donald J. Chisholm. (2013) Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots. Endocrine Reviews 34:4, pages 463-500.
Crossref
Crossref
S M Somerset, K Markwell & M Al-Foraih. (2013) A systematic review of baseline psychosocial characterisation in dietary randomised controlled trials for weight loss. European Journal of Clinical Nutrition 67:7, pages 697-702.
Crossref
Crossref
Indriyanti Rafi Sukmawati & Andi Wijaya. (2013) Adiposopathy and Obesity Paradox. The Indonesian Biomedical Journal 5:1, pages 3.
Crossref
Crossref
Jennifer K. Pepping, Linnea R. Freeman, Sunita Gupta, Jeffrey N. Keller & Annadora J. Bruce-Keller. (2013) NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet. American Journal of Physiology-Endocrinology and Metabolism 304:4, pages E392-E404.
Crossref
Crossref
Olivier Ziegler & Michel Krempf. 2013. Physiology and Physiopathology of Adipose Tissue. Physiology and Physiopathology of Adipose Tissue
397
431
.
Jean-Philippe Bastard & Bruno FèveO. Ziegler & M. Krempf. 2013. Physiologie et physiopathologie du tissu adipeux. Physiologie et physiopathologie du tissu adipeux
405
436
.
Pedro Enrique Miguel Soca, Idania Peña Pérez, Silvio Niño Escofet, Walter Cruz Torres, Aluett Niño Peña & Delmis Ponce De León. (2012) Ensayo clínico aleatorio: papel de la dieta y ejercicios físicos en mujeres con síndrome metabólico. Atención Primaria 44:7, pages 387-393.
Crossref
Crossref
James Rippe & Theodore AngelopoulosRichard Seip. 2012. Obesity. Obesity
381
408
.
Swathi Appachi, Karen R. Kelly, Philip R. Schauer, John P. Kirwan, Stanley Hazen, Manjula Gupta & Sangeeta R. Kashyap. (2011) Reduced Cardiovascular Risk Following Bariatric Surgeries is Related to a Partial Recovery from “Adiposopathy”. Obesity Surgery 21:12, pages 1928-1936.
Crossref
Crossref
S.M. Somerset, L. Graham & K. Markwell. (2011) Depression scores predict adherence in a dietary weight loss intervention trial. Clinical Nutrition 30:5, pages 593-598.
Crossref
Crossref
Harold E. Bays. (2011) Adiposopathy. Journal of the American College of Cardiology 57:25, pages 2461-2473.
Crossref
Crossref
Rodolphe Anty & Maud Lemoine. (2011) Liver fibrogenesis and metabolic factors. Clinics and Research in Hepatology and Gastroenterology 35, pages S10-S20.
Crossref
Crossref
Jun Namkung, Sang Baek Koh, In Deok Kong, Jong-Whan Choi & Byung-Il Yeh. (2011) Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome. Metabolism 60:4, pages 564-568.
Crossref
Crossref
Nazanin Noori, Joel D. Kopple, Csaba P. Kovesdy, Usama Feroze, John J. Sim, Sameer B. Murali, Amanda Luna, Myra Gomez, Claudia Luna, Rachelle Bross, Allen R. Nissenson & Kamyar Kalantar-Zadeh. (2010) Mid-Arm Muscle Circumference and Quality of Life and Survival in Maintenance Hemodialysis Patients. Clinical Journal of the American Society of Nephrology 5:12, pages 2258-2268.
Crossref
Crossref
H. E. Bays, J. M. Gonzalez-Campoy & A. B. Schorr. (2010) What men should know about metabolic syndrome, adiposopathy and ‘sick fat’. International Journal of Clinical Practice 64:13, pages 1735-1739.
Crossref
Crossref
A. Gastaldelli & G. Basta. (2010) Ectopic fat and cardiovascular disease: What is the link?. Nutrition, Metabolism and Cardiovascular Diseases 20:7, pages 481-490.
Crossref
Crossref
Harold E. BaysKathleen M. FoxSusan Grandy. (2010) Anthropometric Measurements and Diabetes Mellitus: Clues to the “Pathogenic” and “Protective” Potential of Adipose Tissue. Metabolic Syndrome and Related Disorders 8:4, pages 307-315.
Crossref
Crossref
Cristina Martínez‐Villaluenga & Elvira González de Mejía. 2010. Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals. Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals
67
85
.
Susanna Vuohelainen, Eija Pirinen, Marc Cerrada-Gimenez, Tuomo A. Keinänen, Anne Uimari, Marko Pietilä, Alex R. Khomutov, Juhani Jänne & Leena Alhonen. (2009) Spermidine is indispensable in differentiation of 3T3-L1 fibroblasts to adipocytes. Journal of Cellular and Molecular Medicine 14:6b, pages 1683-1692.
Crossref
Crossref
Cindy X. Huang, Hocine Tighiouart, Srinivasan Beddhu, Alfred K. Cheung, Johanna T. Dwyer, Garabed Eknoyan, Gerald J. Beck, Andrew S. Levey & Mark J. Sarnak. (2010) Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney International 77:7, pages 624-629.
Crossref
Crossref
Mariana Schroeder, Timothy H. Moran & Aron Weller. (2010) Attenuation of obesity by early-life food restriction in genetically hyperphagic male OLETF rats: Peripheral mechanisms. Hormones and Behavior 57:4-5, pages 455-462.
Crossref
Crossref
Lisa A. Cassis & Sara B. Police. 2010. Adipose Tissue in Health and Disease. Adipose Tissue in Health and Disease
245
263
.
Mariana SchroederOrna Zagoory-Sharon, Liat Shbiro, Asaf MarcoJayson Hyun, Timothy H. Moran, Sheng Bi & Aron Weller. (2009) Development of obesity in the Otsuka Long-Evans Tokushima Fatty rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 297:6, pages R1749-R1760.
Crossref
Crossref
H. E. Bays, B. Laferrère, J. Dixon, L. Aronne, J. M. González-Campoy, C. Apovian & B. M. Wolfe. (2009) Adiposopathy and bariatric surgery: is ‘sick fat’ a surgical disease?. International Journal of Clinical Practice 63:9, pages 1285-1300.
Crossref
Crossref
Yu-Wen Huang, Yue Liu, Slavik Dushenkov, Chi-Tang Ho & Mou-Tuan Huang. (2009) Anti-obesity effects of epigallocatechin-3-gallate, orange peel extract, black tea extract, caffeine and their combinations in a mouse model. Journal of Functional Foods 1:3, pages 304-310.
Crossref
Crossref
Kavitha Bhat Schelbert. (2009) Comorbidities of Obesity. Primary Care: Clinics in Office Practice 36:2, pages 271-285.
Crossref
Crossref
Harold E. Bays. (2009) “Sick Fat,” Metabolic Disease, and Atherosclerosis. The American Journal of Medicine 122:1, pages S26-S37.
Crossref
Crossref
Harold Bays. 2009. Clinical Lipidology. Clinical Lipidology
530
543
.
H. E. Bays, J. M. González-Campoy, R. R. Henry, D. A. Bergman, A. E. Kitabchi, A. B. Schorr & H. W. Rodbard. (2008) Is adiposopathy (sick fat) an endocrine disease?. International Journal of Clinical Practice 62:10, pages 1474-1483.
Crossref
Crossref
Makoto Horikawa, Toshihisa Nomura, Teppei Hashimoto & Kazuichi Sakamoto. (2008) Elongation and Desaturation of Fatty Acids are Critical in Growth, Lipid Metabolism and Ontogeny of Caenorhabditis elegans. The Journal of Biochemistry 144:2, pages 149-158.
Crossref
Crossref
Carlo Maria Rotella & Laura Pala. (2008) Time to insulin in type-2 diabetes: high hurdles or Santiago way?. Acta Diabetologica 45:2, pages 67-74.
Crossref
Crossref
A. J. Scheen. (2008) CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant. Journal of Neuroendocrinology 20:s1, pages 139-146.
Crossref
Crossref
D. Mafra, F. Guebre-Egziabher & D. Fouque. (2008) Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrology Dialysis Transplantation 23:8, pages 2461-2466.
Crossref
Crossref
Jason M. Hollander & Jeffrey I. Mechanick. (2008) Complementary and Alternative Medicine and the Management of the Metabolic Syndrome. Journal of the American Dietetic Association 108:3, pages 495-509.
Crossref
Crossref
Olivia Sánchez Sánchez & José Sabán Ruiz. (2008) Luces y sombras en la aplicación de las nuevas guías para el tratamiento de la diabetes mellitus tipo 2. Consejos prácticos sobre el tratamiento combinado y la insulinoterapia. Medicina Clínica 130:5, pages 188-196.
Crossref
Crossref
Josep Vidal & Ramón Gomis. (2008) Interrelaciones entre obesidad y aterotrombosis. Revista Española de Cardiología Suplementos 8:3, pages 3C-11C.
Crossref
Crossref
Harold E Bays & Ronald B Goldberg. (2007) The ‘Forgotten’ Bile Acid Sequestrants: Is Now a Good Time to Remember?. American Journal of Therapeutics 14:6, pages 567-580.
Crossref
Crossref
Harold BaysJennifer McElhattanBrian S Bryzinski. (2016) A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitus. Diabetes and Vascular Disease Research 4:3, pages 181-193.
Crossref
Crossref
Harold Bays, Helena W. Rodbard, Alan Bruce Schorr & J. Michael González-Campoy. (2007) Adiposopathy: Treating pathogenic adipose tissue to reduce cardiovascular disease risk. Current Treatment Options in Cardiovascular Medicine 9:4, pages 259-271.
Crossref
Crossref
H. E. Bays, R. H. Chapman & S. Grandy. (2007) The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. International Journal of Clinical Practice 61:5, pages 737-747.
Crossref
Crossref
Julie A. Lovegrove. (2007) CVD risk in South Asians: the importance of defining adiposity and influence of dietary polyunsaturated fat. Proceedings of the Nutrition Society 66:2, pages 286-298.
Crossref
Crossref